The shareholders of BarMatin UG are Mr. Dr. Michael Götz and an entrepreneur from Northern Europe. The latter one and was on the board of management protein expression company, which manufactures market relevant proteins with a barley expression platform. Many proteins could be put on the biotech market very successfully. Mr. Dr. Götz is a biochemist with wide experience in heterologous in planta protein expression systems. In the past, he led the biotech division of a renowned plant breeding company and his recent activities are documented in top inernational peer reviewed journals (see Legen et al., (2023) A CRR2-dependent sRNA sequence supports papillomavirus vaccine expression in tobacco chloroplasts. Metabolites (315): 1–13). Mr. Dr. Götz has actively accompanied the development phase of BarMatinTM and in the past he successfully introduced barley varieties into the international seed market. Accordingly, the management of BarMatin UG combines well balanced competences in both biotech as well as plant breeding and in the marketing of high-impact products.
You are coming from the food, plant breeding, beverage or pharmaceutical industry and have interest on BarMatinTM?
Contact us soon!
We answer to all inquiries immediately and discretely! We are pleased for your interest!
